Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 243-053-7 | CAS number: 19430-93-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- no guideline available
- Guideline:
- other:
- Principles of method if other than guideline:
- No guideline available
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Cr1 : CD
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Young adult Crl : CD rats with average bodyweight of 242g.
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- The test material, which was used as received, was administered by intragastric intubation in single doses to a group of 10 young adult Cr1 : CD ® male rats. A range finding study was first conducted in the range 670 - 25000 mg/kg bw to determine the initial dose level for the LD50 test. There were no deaths in the range finding study, so a dose level of 25000 mg/kg bw was selected. Surviving male rats administered 25000 mg/kg bw in the LD50 test were weighed and observed during a 14-day recovery period, and then sacrificed.
- Doses:
- 25000 mg/kg bw
- No. of animals per sex per dose:
- 10 males
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 25 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 0/10
- Clinical signs:
- other: congestion and slight weight loss in one rat
- Interpretation of results:
- relatively harmless
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The oral LD50 of PFBE (3,3,4,4,5,5,6,6,6-nonafluorohexene) in the rat is greater than 25000 mg/kg bw.
- Executive summary:
PFBE (3,3,4,4,5,5,6,6,6-nonafluorohexene) has very low toxicity when administered orally to young adult Crl : CD male rats in single doses. Its LD50 is greater than 25000 mg/kg bw, the maximum feasible dose. There was no mortality, and the only clinical signs observed were congestion and slight weight loss in one rat (out of ten on test).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 25 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
PFBE (3,3,4,4,5,5,6,6,6-nonafluorohexene) has very low toxicity when administered orally to young adult Crl : CD male rats in single doses. Its LD50 is greater than 25000 mg/kg bw, the maximum feasible dose. There was no mortality within the 14 -day observation period and the only clinical signs observed were congestion and slight weight loss in one rat (out of ten on test).
In a sub-acute toxicity study with PFBE in the rat conducted to OECD 412 no treatment related mortality was observed in animals exposed upto 10,000 ppm (100615 mg/m3) for 6 hrs/day for 28 days. Based on this it can be said that the 4hr LC50 (rat) of PFBE will be > 100.6 mg/l, well in excess of the EU upper regulatory limit of 20mg/l for classification for acute toxicity by inhalation.
Justification for selection of acute toxicity – oral endpoint
Standard acute oral toxicity test
Justification for selection of acute toxicity – inhalation endpoint
In a sub-acute toxicity study with PFBE in the rat conducted to OECD 412 no treatment related mortality was observed in animals exposed upto 10,000 ppm (100615 mg/m3) for 6 hrs/day for 28 days. Based on this it can be said that the 4hr LC50 (rat) of PFBE will be > 100.6 mg/l, well in excess of the EU upper regulatory limit of 20mg/l for classification for acute toxicity by inhalation.
Justification for classification or non-classification
In a standard acute oral toxicity test, the LD50 of PFBE (3,3,4,4,5,5,6,6,6-nonafluorohexene) in the rat was judged to be > 25000 mg/kg bw. Therefore, as the LD50 is well in excess of 2000 mg/kg bw, classification for acute toxicity by the oral route is not warranted according to EU Directive 67/548/EEC or the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
In a sub-acute toxicity study with PFBE in the rat conducted to OECD 412 no treatment related mortality was observed in animals exposed upto 10,000 ppm (100615 mg/m3) for 6 hrs/day for 28 days. Based on this it can be said that the 4hr LC50 (rat) of PFBE will be > 100.6 mg/l, well in excess of the EU upper regulatory limit of 20mg/l for classification for acute toxicity by inhalation. Therefore, classification for acute toxicity by the inhalation route is not warranted according to EU Directive 67/548/EEC or the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
